Novartis' Painkiller Pricing Strategy Deemed Legal
Novartis AG on Monday ducked a putative class action alleging it broke New Jersey consumer fraud laws by charging more for a migraine medicine than for another chemically identical painkiller when...To view the full article, register now.
Already a subscriber? Click here to view full article